Abstract: A display substrate includes a pixel driving circuit, which includes a driving circuit, a storage circuit and a reset circuit. The reset circuit is electrically connected to a first terminal of the driving circuit. The driving circuit is used to conduct a path between the first terminal and a second terminal of the driving circuit under the control of a potential at its control terminal. The storage circuit is electrically connected to the control terminal of the driving circuit. The reset circuit includes a first capacitor. The storage circuit includes a second capacitor. An area of an overlap between orthographic projections of a first electrode plate and a second electrode plate of the first capacitor on the base substrate is smaller than that of the second capacitor on the base substrate.

Abstract: A data packet transmission method and apparatus are provided. The method includes: An IAB donor determines first configuration information, where the first configuration information is used to indicate a first backhaul link BH RLC channel, and the first BH RLC channel is used to transmit a control protocol data unit PDU at a backhaul adaptation protocol BAP layer. The IAB donor sends the first configuration information to an IAB node. According to the foregoing procedure, the IAB donor indicates, by using the first configuration information, the IAB node to send the control PDU at the BAP layer through the first BH RLC channel, to implement bearer mapping when the IAB node needs to send the control PDU at the BAP layer.

Abstract: The present disclosure provides a vehicle communication method, apparatus, storage medium and program product, which relates to the field of artificial intelligence.

Abstract: The present disclosure discloses a communication method, apparatus for a vehicle and an electronic device, which relate to the field of artificial intelligence technology such as Vehicle to X, automatic driving and intelligent transportation.

Abstract: Disclosed are daidzein analogs having the formula (I). Also disclosed are compositions, include a disclosed daidzein analogs, methods of preventing or treating bone disease or bone injury and/or stimulating bone growth, in a subject that include administering to the subject an effective amount of disclosed daidzein analog. Disclosed are isolated mesenchymal stem cell that has been altered by treatment a disclosed daidzein analog, daidzein, glycinol, glyceollin I, or glyceollin II, to increase the osteogenic potential of the mesenchymal stem cells.